FLECAINE L.P. 200 mg, extended-release capsule 30 capsules
Active ingredients: Flecainide acetate
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLECAINE L.P. 200 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 gélule(s)
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Apr 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65017848CIP73580587CIP133400935805874Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE FLÉCAÏNIDEgélule | 200 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.